Retatrutide is a synthetic peptide classified as a GGG tri-agonist, studied for its simultaneous activation of GLP-1, GIP, and glucagon receptors. This multifaceted receptor profile positions Retatrutide as a next-generation compound for investigating complex metabolic pathways.

By engaging multiple incretin and glucagon signaling mechanisms, Retatrutide provides researchers with a novel tool to explore energy balance, glucose regulation, and metabolic adaptation in experimental models.

ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human usage.